BACKGROUND: Renal coloboma syndrome (RCS) is a highly variable syndrome characterized by renal and ocular abnormalities. It is associated in about 50 % of cases with mutations of PAX2, a gene encoding a transcription factor required during development. CASE-DIAGNOSIS/TREATMENT: The case study involves two monozygotic twin sisters with RCS showing highly discordant phenotypes. Twin 1 was antenatally diagnosed with multiple cysts in the right kidney. She had complicated vacuum-assisted delivery with acute renal failure. She developed proteinuria at age 4 years, followed by a progressive rise in serum creatinine requiring renal replacement therapy at age 22. No ocular abnormalities have been detected. Twin 2 experienced rapidly reversible acute renal failure without renal morphological abnormalities at birth. At age 2 years, complete visual acuity loss of the left eye secondary to an optic disc coloboma was diagnosed. No significant events occurred until the age of 20, when clinical proteinuria was detected. Proteinuria remission was obtained by multidrug treatment. In both patients, a novel de novo mutation of PAX2 was detected, which leads to the substitution of a highly conserved cysteine (p.C52Y). CONCLUSIONS: The patients described provide an extreme example of clinical variability in RCS. The role of environmental, genetic, and epigenetic factors is discussed.
BACKGROUND:Renal coloboma syndrome (RCS) is a highly variable syndrome characterized by renal and ocular abnormalities. It is associated in about 50 % of cases with mutations of PAX2, a gene encoding a transcription factor required during development. CASE-DIAGNOSIS/TREATMENT: The case study involves two monozygotic twin sisters with RCS showing highly discordant phenotypes. Twin 1 was antenatally diagnosed with multiple cysts in the right kidney. She had complicated vacuum-assisted delivery with acute renal failure. She developed proteinuria at age 4 years, followed by a progressive rise in serum creatinine requiring renal replacement therapy at age 22. No ocular abnormalities have been detected. Twin 2 experienced rapidly reversible acute renal failure without renal morphological abnormalities at birth. At age 2 years, complete visual acuity loss of the left eye secondary to an optic disc coloboma was diagnosed. No significant events occurred until the age of 20, when clinical proteinuria was detected. Proteinuria remission was obtained by multidrug treatment. In both patients, a novel de novo mutation of PAX2 was detected, which leads to the substitution of a highly conserved cysteine (p.C52Y). CONCLUSIONS: The patients described provide an extreme example of clinical variability in RCS. The role of environmental, genetic, and epigenetic factors is discussed.
Authors: Mario F Fraga; Esteban Ballestar; Maria F Paz; Santiago Ropero; Fernando Setien; Maria L Ballestar; Damia Heine-Suñer; Juan C Cigudosa; Miguel Urioste; Javier Benitez; Manuel Boix-Chornet; Abel Sanchez-Aguilera; Charlotte Ling; Emma Carlsson; Pernille Poulsen; Allan Vaag; Zarko Stephan; Tim D Spector; Yue-Zhong Wu; Christoph Plass; Manel Esteller Journal: Proc Natl Acad Sci U S A Date: 2005-07-11 Impact factor: 11.205
Authors: L A Schimmenti; H E Cunliffe; L A McNoe; T A Ward; M C French; H H Shim; Y H Zhang; W Proesmans; A Leys; K A Byerly; S R Braddock; M Masuno; K Imaizumi; K Devriendt; M R Eccles Journal: Am J Hum Genet Date: 1997-04 Impact factor: 11.025
Authors: Matthew Bower; Rémi Salomon; Judith Allanson; Corinne Antignac; Francesco Benedicenti; Elisa Benetti; Gil Binenbaum; Uffe B Jensen; Pierre Cochat; Stephane DeCramer; Joanne Dixon; Regen Drouin; Marni J Falk; Holly Feret; Robert Gise; Alasdair Hunter; Kisha Johnson; Rajiv Kumar; Marie Pierre Lavocat; Laura Martin; Vincent Morinière; David Mowat; Luisa Murer; Hiep T Nguyen; Gabriela Peretz-Amit; Eric Pierce; Emily Place; Nancy Rodig; Ann Salerno; Sujatha Sastry; Tadashi Sato; John A Sayer; Gerard C P Schaafsma; Lawrence Shoemaker; David W Stockton; Wen-Hann Tan; Romano Tenconi; Philippe Vanhille; Abhay Vats; Xinjing Wang; Berta Warman; Richard G Weleber; Susan M White; Carolyn Wilson-Brackett; Dina J Zand; Michael Eccles; Lisa A Schimmenti; Laurence Heidet Journal: Hum Mutat Date: 2012-01-31 Impact factor: 4.878
Authors: Jeffery Fletcher; Min Hu; Yemima Berman; Felicity Collins; John Grigg; Margot McIver; Harald Jüppner; Stephen I Alexander Journal: J Am Soc Nephrol Date: 2005-07-27 Impact factor: 10.121
Authors: S Porteous; E Torban; N P Cho; H Cunliffe; L Chua; L McNoe; T Ward; C Souza; P Gus; R Giugliani; T Sato; K Yun; J Favor; M Sicotte; P Goodyer; M Eccles Journal: Hum Mol Genet Date: 2000-01-01 Impact factor: 6.150
Authors: J Favor; R Sandulache; A Neuhäuser-Klaus; W Pretsch; B Chatterjee; E Senft; W Wurst; V Blanquet; P Grimes; R Spörle; K Schughart Journal: Proc Natl Acad Sci U S A Date: 1996-11-26 Impact factor: 11.205
Authors: P Sanyanusin; L A Schimmenti; L A McNoe; T A Ward; M E Pierpont; M J Sullivan; W B Dobyns; M R Eccles Journal: Nat Genet Date: 1995-04 Impact factor: 38.330
Authors: David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki Journal: Hum Genet Date: 2013-07-03 Impact factor: 4.132
Authors: Rahul Rachwani Anil; Carlos Rocha-de-Lossada; Carlos Hernando Ayala; Manuela España Contreras Journal: Am J Ophthalmol Case Rep Date: 2019-10-11